All In Biotech

Drug Trial Radar · NCT07067463

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Primary Progressive Multiple Sclerosis

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 705 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

705

Planned (sponsor's estimate)

Start

Mar 23, 2026

Primary completion

Jun 2030

Study completion Jul 2030

Sponsor

Lead sponsor
Zenas BioPharma (USA), LLCIndustry
Sponsor type
Industry
First posted
Jul 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Orelabrutinib is a CNS-penetrable BTK inhibitor. This is a phase 3, randomized, double-blind, parallel-group, multicenter study to evaluate the efficacy and safety of orelabrutinib compared with placebo in patients with PPMS. Patients will be treated for approximately 30 to 60 months, with a minimum treatment duration of 12 months. The study will enroll approximately 705 subjects in a 2:1 randomization (orelabrutinib: placebo), globally.

Conditions

  • Multiple Sclerosis (MS) Primary Progressive

Interventions

  • OrelabrutinibDrug

    Orally

  • PlaceboDrug

    Orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to onset of composite confirmed disability progression (cCDP) , confirmed over at least 12 weeks (12-week cCDP)Time frame: Up to approximately 120 weeks

Locations

86 sites in 18 countries. Site status is shown where the registry gives one.

  • Arizona Neuroscience Research, LLC

    Pheonix, Arizona · Recruiting

  • Perseverance Research Center

    Scottsdale, Arizona · Recruiting

  • Regina Berkovich MD, PhD Inc.

    West Hollywood, California · Recruiting

  • Nova Clinical Research, LLC

    Bradenton, Florida · Recruiting

  • Neurology Associates, PA

    Maitland, Florida · Recruiting

  • Neurological Services of Orlando

    Orlando, Florida · Recruiting

  • University of South Florida Department of Neurology - MS Division

    Tampa, Florida · Recruiting

  • University of Kansas Medical Center

    Kansas City, Kansas · Recruiting

  • KC Research Center, PA Neurology Research Department

    Roeland Park, Kansas · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • Cooperman Barnabas Medical Center

    Livingston, New Jersey · Recruiting

  • Velocity Clinical Research, Raleigh Neurology

    Raleigh, North Carolina · Recruiting

  • The Ohio State University Wexner Medical Center (OSUWMC)

    Columbus, Ohio · Recruiting

  • The Boster Center for Multiple Sclerosis

    Columbus, Ohio · Recruiting

  • Premier Neurology

    Greenville, South Carolina · Recruiting

  • Neurology Clinic, P.C.

    Cordova, Tennessee · Recruiting

  • Lone Star Neurology

    San Antonio, Texas · Recruiting

  • Texas Institute for Neurological Disorders - Sherman

    Sherman, Texas · Recruiting

  • Medical College of Wisconsin

    Milwaukee, Wisconsin · Recruiting

  • Neurology Network

    Melbourne, Australia · Recruiting

  • Avis Medica Hospital Pleven

    Pleven, Bulgaria · Recruiting

  • DCC Neoclinic - Sofia

    Sofia, Bulgaria · Recruiting

  • Medical Center Hera EOOD

    Sofia, Bulgaria · Recruiting

  • UMHAT Dr Georgi Stranski

    Pleven, Pleven, Bulgaria · Recruiting

  • Medical Center Nevrocentrum

    Plovdiv, Plovdiv, Bulgaria · Recruiting

  • Diagnostic and Consultative Center Convex

    Sofia, Sofia, Bulgaria · Recruiting

  • Medical Center Medica Plus OOD

    Veliko Tarnovo, Tarnovo, Bulgaria · Recruiting

  • UBC Hospital, University Of British Columbia

    Vancouver, British Columbia, Canada · Recruiting

  • Klinicki Bolnicki Centar Zagreb-Rebro

    Zagreb, Croatia · Recruiting

  • NEUROHK, s.r.o.

    Choceň, Czechia · Recruiting

  • Fakultni Nemocnice Hradec Kralove

    Hradec Králové, Czechia · Recruiting

  • Nemocnice Teplice

    Teplice, Czechia · Recruiting

  • Astra Clinic (Clinic4U)

    Tallinn, Harju, Estonia · Recruiting

  • LTD Pineo Medical Ecosystem

    Tbilisi, Georgia · Recruiting

  • NNLE Jo Ann University Hospital

    Tbilisi, Georgia · Recruiting

  • Caucasus Medical Center Ltd

    Tbilisi, Georgia · Recruiting

  • Raymann, LLC

    Tbilisi, Georgia · Recruiting

  • MD Georgia Staff Physician MediClub Georgia

    Tbilisi, Saburtalo, Georgia · Recruiting

  • Zentrum fur klinische Forschung Dr.Scholl GmbH

    Bad Homburg, Hesse, Germany · Recruiting

  • Neuro Centrum Science Gmbh Albert-Schwitzer

    Erbach im Odenwald, Hesse, Germany · Recruiting

Showing 40 of 86 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.